Answers are grounded in this paper and cite their sources.
BACKGROUND: Artificial intelligence-based clinical decision support systems are promising tools for addressing the increasing complexity of oncological data and treatment. However, the integration and validation of models such as ChatGPT within multidisciplinary decision-making processes for head and neck cancers remain limited. OBJECTIVE: To evaluate the performance of ChatGPT-4 in the management of primary laryngeal cancer and compare it with multidisciplinary tumor board (MDT) decisions. METHODS: The medical records of 25 patients with untreated laryngeal cancer were evaluated using ChatGPT-4 for therapeutic recommendations. The coherence of responses was graded from Grade 1 (totally coherent) to Grade 4 (totally incoherent) and compared with actual MDT decisions. The association between patient features and response grades was also assessed. RESULTS: = 0.506, respectively). CONCLUSION: With further improvements, ChatGPT-4 can be a promising adjunct tool for clinicians in decision-making for primary laryngeal cancer.
No takes yet. Share an insight, caveat, or question.
Pamuk et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: